{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:00:47Z","timestamp":1793235647508,"version":"4.5.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Knowledge of the epidemiology and clinical characteristics of varicella zoster virus (VZV) encephalitis remains limited.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Nationwide prospective cohort study of adults treated for microbiologically confirmed VZV encephalitis at Danish departments of infectious diseases from 2015 to 2019. Modified Poisson regression analysis was used to compute adjusted relative risks (RRs) of unfavorable outcome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 92 adults (49% female) with VZV encephalitis, yielding an incidence of 5.3\/1\u2005000\u2005000 per year (95% CI, 4.2\u20136.6). Median age was 75 years (IQR, 67\u201383) and immunocompromising conditions were frequent (39%). Predominant symptoms were confusion (76%), headache (56%), nausea (45%), gait disturbance (42%), and personality changes (41%). Cranial imaging showed cerebral vasculitis (including infarction and hemorrhage) in 14 (16%) patients and encephalitic abnormalities in 11 (13%) with predilection for the brainstem and deep brain structures. Intravenous acyclovir treatment was initiated a median (IQR) of 13.4 hours (5.2\u201346.3) since admission, while cranial imaging and lumbar puncture were performed after 6.3 hours (2.5\u201331.0) and 18.5 hours (4.9\u201342.0). In-hospital, 1-month, and 3-month mortalities were 4%, 9%, and 11%, respectively. Unfavorable outcome (Glasgow Outcome Score of 1\u20134) was found in 69% at discharge, with age (adjusted RR [aRR], 1.02; 95% CI, 1.01\u20131.03), vasculitis (aRR, 1.38; 95% CI, 1.02\u20131.86), and Glasgow Coma Scale (GCS)\u2005&amp;lt;15 (aRR, 1.32; 95% CI, 1.01\u20131.73) identified as independent risk factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>VZV encephalitis occurs primarily in elderly or immunocompromised patients with a higher incidence than previously estimated. The diagnosis is often delayed; risk factors for unfavorable outcome are age, cerebral vasculitis, and GCS\u2005&amp;lt;15.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciaa185","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T04:39:44Z","timestamp":1582691984000},"page":"1192-1199","source":"Crossref","is-referenced-by-count":79,"title":["Varicella Zoster Virus Encephalitis in Denmark From 2015 to 2019\u2014A Nationwide Prospective Cohort Study"],"prefix":"10.1093","volume":"72","author":[{"given":"Laura Krogh","family":"Herlin","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Aarhus University Hospital, Aarhus N, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer Skaalum","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Aarhus University Hospital, Aarhus N, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Bodilsen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lykke","family":"Larsen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Odense University Hospital, Odense, Denmark"},{"name":"Research Unit for Infectious Diseases, Odense University Hospital, Odense, Denmark"},{"name":"University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Brandt","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Nordsj\u00e6llands Hospital, Hiller\u00f8d, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian \u00d8stergaard","family":"Andersen","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Hvidovre University Hospital, Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte R\u00f8nde","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hvidovre University Hospital, Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Rudolf","family":"L\u00fcttichau","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Herlev Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannik","family":"Helweg-Larsen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Wiese","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Sj\u00e6lland University Hospital, Roskilde, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete","family":"Storgaard","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Aarhus University Hospital, Aarhus N, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine H","family":"Mogensen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Aarhus University Hospital, Aarhus N, Denmark"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"},{"name":"Department of Biomedicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,2,27]]},"reference":[{"key":"2021040811223780700_CIT0001","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcv.2009.07.014","article-title":"Varicella-zoster virus CNS disease\u2014viral load, clinical manifestations and sequels","volume":"46","author":"Persson","year":"2009","journal-title":"J Clin Virol"},{"key":"2021040811223780700_CIT0002","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"2021040811223780700_CIT0003","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1086\/648419","article-title":"Infectious encephalitis in France in 2007: a national prospective study","volume":"49","author":"Mailles","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2021040811223780700_CIT0004","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1080\/135502801753170255","article-title":"Infections of the central nervous system of suspected viral origin: a collaborative study from Finland","volume":"7","author":"Koskiniemi","year":"2001","journal-title":"J Neurovirol"},{"key":"2021040811223780700_CIT0005","first-page":"1483","article-title":"A retrospective review of acute encephalitis in adults in Auckland over a five-year period (2005\u20132009)","volume":"19","author":"Child","year":"2012","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"2021040811223780700_CIT0006","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jinf.2016.09.004","article-title":"Incidence","volume":"74","author":"J\u00f8rgensen","year":"2017","journal-title":"J Infect"},{"key":"2021040811223780700_CIT0007","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jinf.2015.06.004","article-title":"Varicella-zoster virus infections of the central nervous system\u2014prognosis, diagnostics and treatment","volume":"71","author":"Grahn","year":"2015","journal-title":"J Infect"},{"key":"2021040811223780700_CIT0008","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00006454-200108000-00011","article-title":"Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity","volume":"20","author":"Heininger","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"2021040811223780700_CIT0009","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM200003023420906","article-title":"Neurologic complications of the reactivation of varicella-zoster virus","volume":"342","author":"Gilden","year":"2000","journal-title":"N Engl J Med"},{"key":"2021040811223780700_CIT0010","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jinf.2015.04.015","article-title":"Varicella zoster virus immunity: a primer","volume":"71(Suppl 1)","author":"Duncan","year":"2015","journal-title":"J Infect"},{"key":"2021040811223780700_CIT0011","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1172\/JCI92280","article-title":"Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections","volume":"127","author":"Ogunjimi","year":"2017","journal-title":"J Clin Invest"},{"key":"2021040811223780700_CIT0012","doi-asserted-by":"crossref","first-page":"e500","DOI":"10.1212\/NXI.0000000000000500","article-title":"Varicella-zoster virus CNS vasculitis and RNA polymerase III gene mutation in identical twins","volume":"5","author":"Carter-Timofte","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2021040811223780700_CIT0013","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJMra1708714","article-title":"Acute viral encephalitis","volume":"379","author":"Tyler","year":"2018","journal-title":"N Engl J Med"},{"key":"2021040811223780700_CIT0014","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1212\/01.wnl.0000258549.13334.16","article-title":"The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy","volume":"68","author":"Nagel","year":"2007","journal-title":"Neurology"},{"key":"2021040811223780700_CIT0015","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.crad.2016.03.015","article-title":"Neuroimaging in encephalitis: analysis of imaging findings and interobserver agreement","volume":"71","author":"Granerod","year":"2016","journal-title":"Clin Radiol"},{"key":"2021040811223780700_CIT0016","doi-asserted-by":"crossref","first-page":"1102.e1","DOI":"10.1016\/j.cmi.2018.01.016","article-title":"Infectious meningitis and encephalitis in adults in Denmark: a prospective nationwide observational cohort study (DASGIB)","volume":"24","author":"Bodilsen","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2021040811223780700_CIT0017","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/cid\/cit458","article-title":"Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium","volume":"57","author":"Venkatesan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2021040811223780700_CIT0018","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1089\/neu.1998.15.587","article-title":"Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale","volume":"15","author":"Teasdale","year":"1998","journal-title":"J Neurotrauma"},{"key":"2021040811223780700_CIT0019","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"2021040811223780700_CIT0020","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(18)32526-1","article-title":"Acute encephalitis in immunocompetent adults","volume":"393","author":"Venkatesan","year":"2019","journal-title":"Lancet"},{"key":"2021040811223780700_CIT0021","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3201\/eid1909.130064","article-title":"New estimates of incidence of encephalitis in England","volume":"19","author":"Granerod","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"2021040811223780700_CIT0022","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1469-0691.2011.03705.x","article-title":"Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients","volume":"18","author":"De Broucker","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2021040811223780700_CIT0023","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/imj.12749","article-title":"Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand","volume":"45","author":"Britton","year":"2015","journal-title":"Intern Med J"},{"key":"2021040811223780700_CIT0024","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1136\/jnnp.2004.049676","article-title":"Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis","volume":"76","author":"Kamei","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2021040811223780700_CIT0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3851\/IMP2683","article-title":"A systematic review on the role of adjunctive corticosteroids in herpes simplex virus encephalitis: is timing critical for safety and efficacy?","volume":"19","author":"Ramos-Estebanez","year":"2014","journal-title":"Antivir Ther"},{"key":"2021040811223780700_CIT0026","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(09)70134-6","article-title":"Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment","volume":"8","author":"Gilden","year":"2009","journal-title":"Lancet Neurol"},{"key":"2021040811223780700_CIT0027","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/514271","article-title":"Treatment of acute herpes zoster: effect of early (&lt; 48 h) versus late (48-72 h) therapy with acyclovir and valaciclovir on prolonged pain","volume":"178(Suppl 1)","author":"Wood","year":"1998","journal-title":"J Infect Dis"},{"key":"2021040811223780700_CIT0028","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1007\/s00415-013-7057-1","article-title":"Cognitive impairment 3 years after neurological varicella-zoster virus infection: a long-term case control study","volume":"260","author":"Grahn","year":"2013","journal-title":"J Neurol"},{"key":"2021040811223780700_CIT0029","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s004150050078","article-title":"Subcortical type cognitive impairment in herpes zoster encephalitis","volume":"244","author":"Hokkanen","year":"1997","journal-title":"J Neurol"},{"key":"2021040811223780700_CIT0030","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/cid\/cis226","article-title":"Long-term outcome of patients presenting with acute infectious encephalitis of various causes in France","volume":"54","author":"Mailles","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2021040811223780700_CIT0031","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/neu.2011.2137","article-title":"Does the extended Glasgow Outcome Scale add value to the conventional Glasgow Outcome Scale?","volume":"29","author":"Weir","year":"2012","journal-title":"J Neurotrauma"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa185\/33137385\/ciaa185.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/7\/1192\/36985288\/ciaa185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/7\/1192\/36985288\/ciaa185.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T11:23:11Z","timestamp":1617880991000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/72\/7\/1192\/5760851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,27]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,2,27]]},"published-print":{"date-parts":[[2021,4,8]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa185","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,2,27]]}}}